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http://www.biomedcentral.com/1471-2180/14/238RESEARCH ARTICLE Open AccessLM14 defined medium enables continuous
growth of Trypanosoma cruzi
Carla V De Paula Lima1, Michel Batista1, Fernanda G Kugeratski1, Isabel M Vincent3, Maurilio J Soares2,
Christian M Probst1, Marco A Krieger1 and Fabricio K Marchini1*Abstract
Background: Trypanosoma cruzi, the etiologic agent of Chagas disease, alternates between distinct morphological
and functional forms during its life cycle. Axenic multiplication and differentiation processes of this protozoan
parasite can be reproduced in vitro, enabling the isolation and study of the different evolutionary forms. Although
there are several publications attempting the cultivation of T. cruzi under chemically defined conditions, in our
experience none of the published media are capable of maintaining T. cruzi in continuous growth.
Results: In this work we modified a known chemically defined medium for Trypanosoma brucei growth. The
resulting LM14 and LM14B defined media enabled cultivation of five different strains of T. cruzi for more than forty
passages until now. The parasite’s biological characteristics such as morphology and differentiation to metacyclic
trypomastigotes were maintained when defined media is used.
Conclusions: The establishment of a defined medium for T. cruzi cultivation is an important tool for basic biological
research allowing several different approaches, providing new perspectives for further studies related to cell biology
of this parasite.
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Chagas disease is a serious illness discovered by Carlos
Chagas in 1909 [1], which is caused by the protozoan
parasite Trypanosoma cruzi. About 7 to 8 million people
are infected worldwide, mostly in Latin America where
Chagas disease is endemic. In 2008, Chagas disease killed
more than 10,000 individuals [2]. T. cruzi is usually trans-
mitted to humans by the infected feces of blood-sucking
triatomine bugs, although the parasites can also be trans-
mitted through unconventional ways, including blood
transfusions, organ transplants, congenital factors, labo-
ratory accidents and oral transmission by ingestion of
contaminated food [3].
T. cruzi undergoes remarkable morphological and
physiological changes during development in both insect
and mammalian hosts, adopting four distinct forms:
epimastigotes and metacyclic trypomastigotes in the* Correspondence: marchinifk@fiocruz.br
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article, unless otherwise stated.invertebrate vector and amastigotes and bloodstream
trypomastigotes in vertebrate hosts [4]. Epimastigotes
and amastigotes are replicative forms, whereas meta-
cyclic and bloodstream trypomastigotes are infective,
non-replicative forms.
Analysis of differentiation processes such as metacy-
clogenesis (differentiation from epimastigotes to meta-
cyclic trypomastigotes) that lead to infectivity are of great
interest. This differentiation can be reproduced in vitro
[5-7], making it possible to isolate intermediate forms and
study the time course of this process. Although in vitro
metacyclogenesis is conducted under chemically defined
conditions, the cultivation of epimastigote forms (pre-
differentiation stage) is carried on in a complex high
nutritive medium called LIT (Liver Infusion Tryptose)
supplemented with 10% fetal bovine serum (FBS) [8,9].
Several components of this medium have an unknown
composition, including yeast extract, liver infusion, tryp-
tose and FBS. These components may contain growth fac-
tors, vitamins, hormones, proteins, lipids or other factorsCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Furthermore, the quality and origin of the animal sources
of these components are highly variable. These variations
can potentially affect growth and differentiation rates, as
well as responses to drugs, hindering the analysis of ex-
perimental results conducted in this context.
Use of a chemically defined medium for the cultivation
of T. cruzi could improve the current scenario helping
to develop more uniform and standardized assays. For
example, in a drug discovery context, it would bring
more reproducibility and reliability to the testing of new
trypanocidal drugs, as well as studying their effects and
their mechanisms of action in this parasite [10-12]. In
addition, use of a defined medium is essential for many
useful assays, such as perturbation of medium compo-
nents, cellular metabolic labeling and measurement of
metabolites secreted by cells in the medium.
Several articles have already been published showing
the cultivation of different strains of T. cruzi epimasti-
gotes in defined media. In 1977, Azevedo and Roitman
published a research note [13] communicating the con-
tinuous cultivation of Y strain in a defined medium –
AR-103 – which was developed based on a previous
defined medium for cultivation of T. brucei procyclic
cells named HX25 [14]. In 1975, Anderson and Krassner
[15], as well as Cross and coworkers [16], showed suc-
cessful cultivation of Costa Rica and Sonya strains,
respectively, in HX25 defined medium. Avila and co-
workers cultivated strains Y, Ma, Fl and Marin-1 of
T. cruzi in a defined medium containing only D-glucose,
inorganic salts, some vitamins, nucleotides and bovine
liver catalase [17]. Later they developed a minimal
medium based on the previous, where nucleotides
and vitamins had been excluded [18]. However, these
results were criticized by O’Daly and Rodriguez [19],
since they showed the existence of 25 to 30 protein
bands as well as DNA and RNA polymers contamin-
ating the solution of bovine liver catalase used in the
medium.
Thereafter, few published reports showed the cultiva-
tion of T. cruzi in a defined medium, and all of them
only for a single passage, highlighting the challenge of
continuously cultivating this parasite over long periods
under defined conditions.
In the present work we demonstrate a continuous cul-
tivation of T. cruzi epimastigote cells in two defined
media derived from HX25M [20], named LM14 and
LM14B. With these media, we cultivate five different
strains of T. cruzi for more than forty passages. Morph-
ology in defined conditions was maintained, as well as
the parasite’s ability to differentiate to infective forms.
Defined media described herein are powerful tools, in-
dispensable for the application of several methods that
could not be performed using non-defined media.Results and discussion
HX25M and AR-103 media are not sufficient for T. cruzi
cultivation
LITB+FBS is a complex high nutritive medium in which
T. cruzi is routinely cultivated. The high complexity of
the medium makes it infeasible to modify, removing or
replacing its components. For this purpose, we tested
the growth and maintenance of T. cruzi cells in both de-
fined media AR-103 and HX25M. HX25M was devel-
oped to cultivate T. brucei cells [20], and has also been
used to cultivate T. cruzi [15,16], while AR-103 was de-
veloped based on HX25M and is used only for T. cruzi
cultivation [13].
To evaluate the growth rate of cells cultivated in de-
fined media, AR-103 and HX25M media were tested for
T. cruzi cultivation (strain Dm28c). Growth rates after
three days of cultivation were compared with LITB+FBS
medium, the routinely used medium for T. cruzi cultiva-
tion, and LITB without FBS, once FBS is absent in
defined media. Cultures were maintained over five pas-
sages (Figure 1), all starting from 1e + 06 cells/ml. After
the fourth passage, there was no cell growth in both
HX25M or AR-103, indicating that these media do not
support T. cruzi Dm28c cell growth in these conditions.
We obtained similar results in independent experiments
performed using different batches of media at different
times and using different types of flasks and plates (data
not shown).
Putrescine allows continuous growth of T. cruzi in
defined media
T. cruzi epimastigotes are auxotrophic for diamines,
such as putrescine since T. cruzi, unlike other trypanoso-
matids, lacks the genes encoding either ornithine de-
carboxylase or arginine decarboxylase (ODC and ADC),
enzymes responsible for putrescine biosynthesis [21-23].
Diamines are essential for cell proliferation, differenti-
ation and macromolecular synthesis [24]. T. cruzi is able
to convert exogenous putrescine to trypanothione and ca-
daverine to homotrypanothione, antioxidants which are
unique to the kinetoplastids and fulfill many of the roles
ascribed to glutathione in other eukaryotic cells [25].
AR-103 and HX25M media lack diamines in their for-
mulations, requiring the addition of at least one of them.
Therefore, we tested cultivation of T. cruzi in defined
media supplemented with 10 micromolar of putrescine
(HX25M+P and AR-103+P). Figure 2 shows that para-
sites cultivated in AR-103+P died after the fourth pas-
sage (dashed line), whereas parasites in HX25M+P
exhibited continuous growth, with increasing growth
rate after several passages (green line).
These results show that defined media AR-103 and
HX25M were not sufficient for continuous cultivation
of T. cruzi cells, contradicting the results obtained by
Figure 1 Growth comparison between defined (HX25M and AR-103) and complex (LITB+FBS and LITB without FBS) media.
Epimastigote cells counts were performed every three days, then all cultures were diluted to 1e + 06 cells/ml (start point of cultivation). Values
plotted refer to the average of three biological replicates counted every cell passage after three days of cultivation. Cell cultivation in LITB+FBS
(black line) and LITB without FBS (dashed line) was maintained for five passages of three days, whereas defined media HX25M (red line) and
AR-103 (green line) did not support cell growth after the third passage.
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and Cross et al. [16], being putrescine an essential com-
pound for this purpose. AR-103 medium, even with pu-
trescine, does not sustain continuous growth of T. cruzi
in our hands.
Putrescine is greater than 97% pure and since addition
of this compound alone, to a final concentration of 10
micromolar, was sufficient to convert medium from
non-growth sustaining to growth sustaining we can rule
out that any contaminant as being responsible for the
acquired growth.Figure 2 Putrescine and biopterine test in cell culture. Putrescine was
(HX25M+P) and AR-103 (AR-103+P). Biopterin was added at final conce
without (HX25M+B) putrescine. Epimastigote cells counts were performed
(start point of cultivation). Values plotted refer to the average of three biologi
Epimastigote cultures were maintained for six passages in HX25M+P defined
medium (dashed line), even with putrescine, died after the third passage.
the third passage. Epimastigotes cultivated in HX25M+P+B medium (black
HX25M+P medium (P < 0.01) (green line).Biopterin accelerates T. cruzi growth in defined medium
Biopterin is a biologically significant pterin that functions
as an essential cofactor for several enzymes involved in
processes including hydroxylations, ether-lipid cleavage,
and nitric oxide synthase [26-28]. Some trypanosomatids,
like Leishmania, Crithidia and T. brucei, are unable to
synthesize the pterin moiety from GTP (guanosine tri-
phosphate) and thus must acquire pteridines from the
host by salvage mechanisms [29-31].
Biopterin was added to defined medium, with
(HX25M+P+B) or without (HX25M+B) putrescine, at aadded at 10 μM final concentration in defined media HX25M
ntration of 1 μM in defined medium HX25M with (HX25M+P+B) or
every three days, then all cultures were diluted to 1e + 06 cells/ml
cal replicates counted every cell passage after three days of culture.
medium (green line), whereas cells cultivated in AR-103+P defined
Epimastigotes cultivated in HX25M+B medium (red line) died after
line) showed a significant increase in growth rate compared to
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sured by counting at every three days of cultivation for five
passages. Biopterin was not sufficient for continuous culti-
vation of T. cruzi without putrescine (Figure 2, HX25M+B,
red line), but addition of biopterin to HX25M+P medium
significantly increased the growth rate of the parasites com-
pared to medium without biopterin HX25M+P (P < 0.01)
(Figure 2, HX25M+P+B, black line).
The results presented above show that putrescine is
required for T. cruzi epimastigote cultivation and biop-
terin shows growth stimulation of these parasites. These
modified media were named LM14 (HX25M+P) and
LM14B (HX25M+P+B).
Comparisons between parasite growth curves in de-
fined and complex media were obtained by cultivating
epimastigote forms at an initial density of 1e + 06 cells/
ml, until they reached stationary phase or cell death. Sta-
tionary growth phase was reached on the 7th day for
LM14 (2.8e + 07 cells/ml) and LITB without FBS (3.4e +
07 cells/ml) (Figure 3). As observed in LITB+FBS cul-
tures, stationary growth phase of parasites cultivated
in LM14B is reached at the 5th day (3e + 07 cells/ml)
(Figure 3). Although growth rate of parasites culti-
vated in LM14B is slower than in LITB+FBS, when
compared to cells growing in LITB without FBS it is
notably faster. This result suggests that LM14B de-
fined medium is better suited for T. cruzi growth
than the standard medium LITB when FBS is absent.
To verify whether there are any undefined protein
and/or DNA fragment present, we performed a SDS-
polyacrylamide electrophoresis as well as an agarose gel
electrophoresis of tested medium (data not shown). Only
a 60–70 kDa protein was observed, mass related to albu-
min [32], which is added to the defined medium (bovine
serum albumin – BSA). Also we did not observe any DNAFigure 3 In vitro growth curve of T. cruzi in defined (LM14 and LM14B
Epimastigote cells counts were performed at every 24 hours, for eight days
biological replicates. Epimastigotes cultivated in defined medium LM14B (r
LITB+FBS (black line), reaching the stationary phase at 5th day, as well as a
LM14 (green line) and LITB w/o FBS (dashed line).fragment in the defined media. These results indicate that
there are no protein or DNA contaminants in the tested
defined medium, at least with the sensibility reached by
the detection methodology used.
Parasites cultivated in LM14 and LM14B defined media
can differentiate in vitro into metacyclic trypomastigotes
In vitro metacyclogenesis was performed to test the bio-
logical capability of T. cruzi cells to differentiate after
cultivation in the defined medium. Epimastigotes forms
cultivated in LM14 defined medium showed a differenti-
ation rate of about 30% to metacyclic trypomastigotes
after 72 hours of differentiation, a similar differentiation
rate found in parasites from LITB+FBS medium (about
32% of metacyclic trypomastigotes) under the same con-
ditions. We also observed spontaneous metacyclic trypo-
mastigote forms from the third day of culture in LM14
medium, before the stimuli for differentiation (Figure 4
upper panel, 5D EPI and STRESS). Interestingly, para-
sites cultivated in LM14B defined medium, although
exhibiting a better growth rate than in LM14 and ab-
sence of spontaneous metacyclic trypomastigotes before
the stress stimuli, they showed a much lower differenti-
ation rate, about 18% of metacyclic trypomastigotes after
72 hours of differentiation. This event can be compared
to that observed in Leishmania major, where a tetrahy-
drobiopterin (the active form of biopterin) deficiency in
promastigote forms increased differentiation into the
mammalian-infectious metacyclic promastigote form,
probably indicating a role of pterins in resistance to oxi-
dative stress, but the underlying mechanism remains ob-
scure [33,34].
Although parasites from LM14B exhibit a lower dif-
ferentiation rate compared to those in LITB+FBS, the
process is still occurring in this condition and can be) and complex (LITB+FBS and LITB without FBS) media.
(beginning of cell death). Values plotted refer to the average of three
ed line) had a similar profile of growth curve to parasites cultivated in
similar growth curve was observed for epimastigotes cultivated in
Figure 4 Parasite morphology during metacyclogenesis in defined (LM14, LM14B) and complex (LITB + FBS) media. Cells were panoptic
stained (Laborclin, Pinhais, Parana, BR). Images are related to epimastigotes after three days of cultivation (3D EPI), five days of cultivation (5D EPI),
parasites in TAU medium for nutritional stress (STRESS) and metacyclic trypomastigotes after in vitro metacyclogenesis (META). The upper panel
shows parasites from defined medium LM14, where spontaneous metacyclic trypomastigotes are observed in the early stationary growth (5D EPI
and STRESS). The middle panel shows parasites from the defined medium LM14B in different stages of differentiation. The lower panel shows
parasites from LITB+FBS medium (complex medium). Metacyclic trypomastigotes are indicated with an asterisk. Size bar indicates 10 μm.
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higher differentiation rate. This represent a strong indi-
cation that the biological capabilities of T. cruzi in our
defined medium are maintained.
We also analyzed the ultrastructure of T. cruzi epimas-
tigotes cultivated in LITB+FBS, LITB without serum and
LM14B media to verify possible morphological alter-
ations in cells cultivated in defined medium, when com-
pared with conventional complex medium. Analysis of
T. cruzi ultrathin sections by transmission electron mi-
croscopy showed no visible alteration in cell shape or
intracellular organelle content (data available in Additional
file 1), showing that the morphology of T. cruzi cultivated
in LM14B is maintained.
Different T. cruzi strains can be cultivated in LM14B
defined medium
T. cruzi is a highly polymorphic specie. The biological,
biochemical and genetic diversity of T. cruzi isolates has
long been recognized [35-37]. Over the years, several ap-
proaches have been used to separate the T. cruzi popula-
tion into different groups, or discrete typing units
(DTUs). Recently, Zingales and coworkers reorganized
by consensus the nomenclature of these DTUs as TcI-
TcVI [38].
We selected strains from different DTUs to test their
suitability to grow in LM14B defined medium. They
were: Colombiana and Dm28c (DTU I), Esmeraldo
(DTU II), CL14 and CL Brener (DTU VI). Our findings
clearly demonstrate that LM14B medium was efficientfor cultivating all tested T. cruzi strains in defined condi-
tions, even better than cultivation in LITB medium with-
out FBS (Figure 5).
Conclusion
Our data report the development of a defined medium
for T. cruzi cultivation. Despite previously published
work reporting sustained cultivation of T. cruzi in de-
fined medium, we could not reproduce such results.
Therefore, to our knowledge, LM14 and LM14B are the
only chemically defined medium capable of continuous
axenic T. cruzi cultivation (more than forty passages
until now for all the tested strains) while maintaining
T. cruzi morphology and ability to differentiate. Both de-
fined media described herein present important ad-
vances to study the cell biology of this parasite, since
they enable metabolic labeling, drugs research and
evaluation, metabolic studies, among other powerful
methods, providing new perspectives for further studies
related to T. cruzi biochemistry.
Methods
Defined media preparation
All components of both AR-103 and HX25M defined
media were individually dissolved in appropriate solvent,
at concentrations under each limit of solubility. The re-
quired amount of each component for 1 liter of medium
was added to 500 ml of distilled water and mixed under
constant agitation at room temperature until complete
dissolution. After, the medium pH was adjusted to 7.2
Figure 5 Growth evaluation of different T. cruzi strains in LM14B defined medium. Epimastigote counts were performed at every three
days, then all cultures were diluted to 1e + 06 cells/ml (start point of cultivation). Values plotted refer to the average of three biological replicates,
with counts at every third day of culture.
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The volume was set to 1 liter with water. Finally, the
medium was sterilized using a 0.22 μm filter.
The final LM14B medium formulation and method of
preparation can be found in Additional file 2.
Trypanosoma cruzi growth
The experiments were performed using the T. cruzi strain
Dm28c [7]. Culture epimastigote forms were maintained
at 28°C in LITB medium supplemented or not with 10%
fetal bovine serum (FBS) [8,9], by passages every three
days from an initial density of 1e + 06 cells/ml in fresh
medium.
Cell cultures in defined media were obtained from cul-
tures previously cultivated in LITB+FBS medium. In
order to eliminate LITB+FBS medium before cultivation
in defined media, cells were washed twice in sterile
phosphate saline buffer (137 mM NaCl, 2.7 mM KCl,
4.3 mM Na2HPO4, 1.5 mM KH2PO4). Media evaluation
was performed with three biological replicates and pas-
sages every three days of 1e + 06 cells/ml. After confirm-
ation of continuous and stable growth of cultures over
several passages, a growth curve was obtained with three
biological replicates, using an initial concentration of
1e + 06 cells/ml, and daily counting until cultures reached
stationary phase, or until start of cell death.All cultures were maintained in 15 ml conical centri-
fuge tubes, at a final volume of 3 ml. Epimastigote cells
counts were performed using an automatic counter (Z2
Coulter® – Beckman Coulter).
To test the suitability of LM14B to maintain growth
of different strains of T. cruzi, the CL14, CL Brener,
Colombiana and Esmeraldo strains were tested [39]. All
were cultivated in LITB+FBS, LITB without FBS and
LM14B medium with passages every three day from an
initial density of 1e + 06 cells/ml in fresh medium. Cells
were harvested from LITB+FBS media by centrifugation
at 7,000 × g for 5 min at 20°C and washed in sterile
phosphate saline buffer before starting the experiment.
Data were compared via two-way analysis of variance
(ANOVA) followed by Bonferroni multiple range test for
statistically significant differences at p < 0.05.
In vitro metacyclogenesis
Aiming to verify if biological characteristics of parasites
are maintained in defined medium, we performed in vitro
differentiation from epimastigotes forms (replicative) to
metacyclic trypomastigotes forms (infective), a process
known as metacyclogenesis [5]. For this purpose, epi-
mastigotes were harvested from LITB+FBS, LM14 and
LM14B media after 5 days of culture (early stationary
phase), by centrifugation at 7,000 × g for 5 min at 20°C.
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incubation at 28°C in TAU medium (190 mM NaCl,
17 mM KCl, 2 mMMgCl2, 2 mM CaCl2, 8 mM phosphate
buffer pH 6.0) for 2 hours at a concentration of 5e + 08
cells/mL. Next, cultures were diluted 1:100 in TAU3AAG
medium (TAU supplemented with 10 mM L-proline,
50 mM L-sodium glutamate, 2 mM L-sodium aspartate,
and 10 mM D-glucose). After 96 h of incubation, differen-
tial counts between epimastigotes and metacyclic trypo-
mastigotes forms were performed in Neubauer chamber
to determine the differentiation rates.
Additional files
Additional file 1: Ultrastructural morphology of T. cruzi
epimastigotes under cultivation in different culture media.
Additional file 2: LM14B preparation method.
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